Key Takeaways
- Among 705 differentiated thyroid cancer (DTC) surgeries using Intraoperative Neurophysiological Monitoring (IONM), 8.9% (63/705) demonstrated abnormal signals, decomposed into true RLN injury 5.9% (42/705), transient injury 1.6% (11/705), and false injury 1.4% (10/705).
- Tumor invasion or adhesion was a significantly more frequent cause of true RLN injury (21.4%, 9/42) than of transient or false injury (P < 0.05); all true injuries had postoperative laryngoscopic abnormalities, and 64.3% (27/42) reported hoarseness or liquid-aspiration cough.
- Transient IONM signal abnormality (recovery after ≥10 min pause and dexamethasone) occurred in 90.9% (10/11) of transient injuries versus only 21.4% (9/42) of true injuries and 40.0% (4/10) of false injuries (P < 0.05), indicating that signal recovery is a meaningful but imperfect predictor of postoperative vocal cord function.
- Most RLN injuries occurred in nerves with a normal macroscopic appearance (83.0%, 44/53), underscoring that visual integrity does not equate to functional integrity and that transient signal loss demands immediate operative pause and nerve protection.
Clinical Context
Recurrent Laryngeal Nerve (RLN) injury remains one of the most consequential complications of thyroid surgery, with reported rates of approximately 2.3%–7.4%. IONM has become an established adjunct for nerve localization, identification of anatomical variants such as the Non-recurrent Laryngeal Nerve (NRLN), and intraoperative troubleshooting of suspected injury sites. However, existing guidelines do not adequately address the phenotypic spectrum of abnormal IONM signals—specifically, how to distinguish true injury from transient injury and false-positive Loss of Signal (LOS), and what such signals imply for prognosis.
This gap has direct intraoperative consequences. When a Loss of Signal (LOS) occurs, the surgeon must decide whether to pause, whether to abandon the contralateral side in a planned total thyroidectomy, and how to counsel the patient postoperatively. Clinical data from a high-volume tertiary surgical center (Beijing Friendship Hospital, Capital Medical University) now provide a structured framework for interpreting abnormal signals by correlating IONM findings with surgical records, postoperative symptoms, and laryngoscopy within 14 days.
Clinical Evidence & Cohort Breakdown
This retrospective analysis included 705 patients (≥18 years) with pathologically confirmed DTC undergoing primary radical thyroidectomy with IONM between January 2018 and December 2020. Preoperative laryngoscopy was normal in all patients, and none had baseline hoarseness or aspiration. Surgery comprised open and endoscopic approaches with routine central compartment dissection; lateral neck dissection and parathyroid autotransplantation were performed selectively.
IONM signal abnormality was defined as loss of V2/R2 or amplitude attenuation below 50% of the V1/R1 baseline. On detection, the surgeon paused for ≥10 minutes, infiltrated the RLN with dexamethasone, and re-tested. Recovery to >50% of baseline defined a transient signal abnormality.
| Outcome Category | Definition | Incidence (n/705) | Key Associations |
|---|---|---|---|
| True RLN injury | LOS plus ≥1 of: postoperative laryngoscopic abnormality; intraoperative nerve discontinuity; persistent hoarseness/aspiration | 5.9% (42) | Tumor invasion/adhesion 21.4% (9/42); 100% laryngoscopic abnormality; 64.3% symptomatic |
| Transient RLN injury | Intraoperative injury signs with normal postoperative laryngoscopy and symptom resolution | 1.6% (11) | Predominantly traction/compression; all with normal nerve appearance |
| False injury | IONM abnormality only, no true or transient injury | 1.4% (10) | Equipment/anesthesia-related; 40.0% transient signal |
| Overt RLN injury | Visible discontinuity or morphological change | 1.3% (9) | All were true injuries |
| Non-overt RLN injury | Normal-appearing nerve, injury not visually determinable, excluding false injury | 6.2% (44) | 33 true injuries (4.6%), 11 transient (1.6%) |
Signal characteristics by injury type:
| IONM Feature | True Injury (n=42) | Transient Injury (n=11) | False Injury (n=10) | P value |
|---|---|---|---|---|
| Signal loss / attenuation <50% | 34 / 8 | 8 / 3 | 5 / 5 | 0.13 |
| Persistent / transient signal abnormality | 33 / 9 | 1 / 10 | 6 / 4 | <0.01 |
| Transient abnormality rate | 21.4% (9/42) | 90.9% (10/11) | 40.0% (4/10) | <0.05 |
Tumor diameter and tumor invasion of the RLN differed significantly between patients with and without IONM abnormalities (P < 0.01 for both). Notably, of 13 patients with pathologically confirmed tumor invasion of the RLN, 6 (46.2%) had IONM abnormalities—all true injuries—while 7 (53.8%) had no signal abnormality and preserved nerve integrity and function, suggesting that meticulous dissection can preserve a functioning nerve even in the setting of invasion.
Intraoperative IONM Protocol & Technical Pearls
The protocol below reflects the standardized intermittent IONM (I-IONM) workflow used in this cohort, using the V1, R1, R2, V2 signals sequence with a Monopolar Stimulating Probe and EMG Endotracheal Tube (EMG Tube).
- Establish baseline V1. After induction and confirmation of adequate Neuromuscular Blockade (NMB) reversal, stimulate the Vagus Nerve (VN) with 1.0–3.0 mA and record the maximum EMG Amplitude (μV) as the V1 signal. Verify correct Endotracheal Tube (ETT) Malposition has been excluded before accepting the baseline.
- Obtain R1 before nerve exposure. Prior to full dissection of the RLN, stimulate and record the maximum amplitude as the R1 signal. This establishes the pre-dissection functional reference for the nerve segment.
- Monitor continuously during dissection. Re-probe the RLN repeatedly throughout exposure, comparing real-time amplitude and Latency (ms) against R1. Watch for Combined Events (CE)—simultaneous loss of VN and RLN signal—which localize injury between the two stimulation points.
- Map the EBSLN at the superior pole. Before and after ligation of the superior thyroid vessels, probe the External Branch of the Superior Laryngeal Nerve (EBSLN) region at 1.0–1.5 mA (S1/S2 signals) to avoid traction or thermal injury during pedicle division.
- Re-test V2 and R2 after lobectomy and after level VI dissection. A decline of V2/R2 below 50% of V1/R1 constitutes an abnormal signal. Repeat testing after central compartment dissection, since nodal clearance can generate minor nerve trauma.
- Respond to LOS immediately. Pause all dissection for ≥10 minutes, apply dexamethasone infiltration to the RLN, and remove the offending mechanism (traction, compression, thermal spread, or ligature). Re-probe to determine whether the signal recovers above 50% of baseline.
- Interpret recovery cautiously. A transient signal abnormality strongly favors transient injury (90.9% in this cohort) but does not exclude true injury (21.4%). Persistent LOS carries a substantially higher likelihood of true injury and should prompt consideration of staging the contralateral side.
- Document signal level, site, and distance from laryngeal entry. Record whether the abnormality lies at the laryngeal entry point, within ≤2 cm, or >2 cm from entry, along with laterality and persistence, to guide postoperative surveillance.
Clinical Implications for Surgeons & IONM Specialists
The central message for the operating team is that an anatomically intact RLN is not a functionally safe RLN. In this series, 83.0% (44/53) of injured nerves appeared macroscopically normal, and 61.1% of non-overt injuries were true injuries. Traction injury and thermal injury frequently leave no visual trace; only IONM exposes them. Surgeons should therefore treat a transient LOS as an actionable warning rather than an artifact—if the operation is not paused and the nerve protected, a transient injury may convert to a true injury.
Second, signal recovery is informative but not definitive. The significant difference in transient signal abnormality rates across injury types (P < 0.05) supports using recovery as a prognostic guide for postoperative vocal cord function, but the 21.4% transient-abnormality rate among true injuries means recovery cannot be used to rule out injury. Conversely, the 40.0% transient rate among false injuries reflects non-neural causes—instrument malfunction, Subdermal Needle Electrodes dislodgement, ETT malposition (too deep, too shallow, or rotated), poor surface-electrode contact with the vocal cords, and excessive anesthetic dosing—which must be systematically excluded before accepting an LOS as genuine.
Third, tumor invasion is not an absolute contraindication to nerve preservation. Among 13 patients with pathologically confirmed RLN invasion, 7 retained normal signal and function after meticulous sharp dissection. IONM-assisted peeling of the nerve from adherent or invasive tissue, maintaining anatomical continuity, offers a realistic chance of functional preservation. Giant tumor compression and direct infiltration remain high-risk features requiring heightened vigilance.
Finally, this cohort found no significant association between endoscopic approach, extent of lymph node dissection, or clinicopathological variables and RLN injury type—a finding that diverges from some prior reports and likely reflects institutional selection criteria and operator experience. Readers should interpret this cautiously given the retrospective, single-center design, the absence of routine laryngoscopy beyond 3 months (limiting permanent-versus-transient classification), and inherent selection bias. Prospective randomized data, including evaluation of Continuous IONM (C-IONM) in DTC, are awaited.
Reference
Xu W, Zhao N, Min YY, Jiang HP, Wu YD, Wang L, Zhang DQ, Teng CS. Role of abnormal IONM signal in judging the type and prognosis of recurrent laryngeal nerve injury in thyroid cancer surgery. Chinese Journal of Practical Surgery. 2023;43(2):193-197, 202. DOI: 10.19538/j.cjps.issn1005-2208.2023.02.13
Medical Disclaimer: This article is provided for educational and informational purposes only and does not constitute medical advice. Clinical decisions regarding Intraoperative Neurophysiological Monitoring (IONM) technique, signal interpretation, and surgical management of the Recurrent Laryngeal Nerve (RLN) should be individualized to each patient and made by qualified surgical and neurophysiological teams in accordance with current institutional protocols and professional guidelines. The original study is retrospective and single-center; its findings should be validated against broader prospective evidence before adoption into routine practice.